Skip to main content

Table 2 Treatment characteristics

From: DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)–a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume

Total dose (Gy)

 

 Primary tumor

 

Group 1

73.8

Group 2

79.2

Group 3

84.6

Group 4

90.0

 Nodes (median, range)

59.4 (54.0–73.8)

 Nodes electively*

45.0

Fractional dose (Gy)

1.8 bid

Interval

>10 h

Treatment duration (days, median, range)

33 (29–42)

Chemotherapy before radiotherapy (patients, %)

106 (66)

 Cycles (n, range)

2 (1–6)

  1. * to sites about 6 cm cranial to macroscopically involved nodes.